07/2024
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Aug »
07/2024
Jul 24, 2024, 00:57 |
Insight
Anand Patel: Myeloid neoplasms after MTX have features more similar to de-novo
Anand Patel, Assistant Professor and Director of the Inpatient Leukemia Service at the University of…
Jul 24, 2024, 00:56 |
Opinion
Bethel Adefres: The 2024 World Congress of Brachytherapy
Bethel Adefres, Radiation Oncologist at Yale University, shared on X: "Last week at the 2024…
Jul 24, 2024, 00:56 |
Blog
BaDoi Phan: Excited to teach single-cell RNA-seq analysis in research
BaDoi Phan, MD/PhD Trainee at Carnegie Mellon University, shared on X: "Excited to teach single-cell…
Jul 24, 2024, 00:55 |
Blog
Carolyn Ee: The role of GPs in implementing the Australian Cancer Plan
Carolyn Ee, Associate Professor of Cancer Survivorship and Primary Care at Flinders University shared on…
Jul 24, 2024, 00:55 |
Positive
Mayor Emmett Jordan of City of Greenbelt in Maryland for issues a PSA about lung cancer screening - ALCSI
The American Lung Cancer Screening Initiative (ALCSI) shared on X: "Thank you to Mayor Emmett…
Jul 24, 2024, 00:55 |
Blog
Yale Advancements in Oncology: Implementing the Best Science from ASCO24 and Beyond
Yale Cancer Center shared on X: "Register now for Yale Advancements in Oncology: Implementing the…
Jul 24, 2024, 00:55 |
Blog
2-day workshop on cervical cancer elimination in Latin America and the Caribbean - Sylvester Comprehensive Cancer Center
Sylvester Comprehensive Cancer Center shared on X: "We held a 2-day workshop, alongside PAHO/WHO and…
Jul 24, 2024, 00:54 |
Blog
12 leaders selected for the 2024-2025 ASCO Leadership Development Program
American Society of Clinical Oncology (ASCO) shared a post on LinkedIn: "We congratulate the 12…
Jul 23, 2024, 22:30 |
Blog
Hagop Kantarjian: The simultaneous combination of ponatinib and blinatumomab highly effective
Hagop Kantarjian shared on X: "The simultaneous combination of ponatinib and blinatumomab highly effective: MRD-negativity rate…
Jul 23, 2024, 15:52 |
Drugs
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
In the rapidly evolving field of oncology, we are witnessing remarkable advancements in various treatment…
80
81
82
83
84
All:
3004
Posts:
811 - 820
Agenus CEO Dr. Garo Armen Honored with WITSA Eminent Person 2024 Award for Cancer Immunotherapy Breakthrough
Vivek Subbiah: Key publications leading to Nobel Prize 2024, published in 1993
Victor Ambros and Gary Ruvkun Awarded 2024 Nobel Prize in Medicine for MicroRNA Discovery
Dr. Zainab Shinkafi-Bagudu: Advocating for Equity in Cancer Care - UICC Presidential Candidacy
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 6
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube